No benefit found to selecting dose of blood thinner based on patients' genetic makeup
Wednesday, November 20, 2013 - 22:30
in Health & Medicine
A new study led by researchers has determined that a gene-based method for selecting patients' doses of the popular heart medication warfarin is no better than standardized dosing methods.